CIK: 0001595851 · Show all filings
Period: Q1 2016 (← Previous) (Next →)
Filing Date: May 16, 2016
Total Value: $177M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SERIES TRUST | 220,000 | $11.04M | 6.2% | $50.17 | — | — | Put | 78464A870 |
| ACAD | ACADIA PHARMACEUTICALS INC | 350,000 | $9.786M | 5.5% | $27.96 * | $35.23 | -38.0% | Put | 004225108 |
| — | CELGENE CORP | 90,202 | $9.028M | 5.1% | $100.09 | $100.09 | — | COM | 151020104 |
| EW | EDWARDS LIFESCIENCES CORP | 100,000 | $8.821M | 5.0% | $88.21 | — | — | Call | 28176E108 |
| BSX | BOSTON SCIENTIFIC CORP | 450,000 | $8.465M | 4.8% | $18.81 * | $17.57 | 0.0% | COM | 101137107 |
| IWM | ISHARES TR | 75,000 | $8.297M | 4.7% | $110.63 | — | — | Put | 464287655 |
| — | HORIZON PHARMA PLC | 425,000 | $7.042M | 4.0% | $16.57 | $16.57 | — | SHS | G4617B105 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 700,000 | $5.95M | 3.4% | $8.50 * | $8.97 | +9.6% | COM | 69404D108 |
| ABBV | ABBVIE INC | 100,000 | $5.712M | 3.2% | $57.12 | — | — | Call | 00287Y109 |
| AGIO | AGIOS PHARMACEUTICALS INC | 140,000 | $5.684M | 3.2% | $40.60 * | $42.75 | 0.0% | COM | 00847X104 |
| — | ALEXION PHARMACEUTICALS INC | 40,000 | $5.569M | 3.2% | $139.22 | $139.22 | — | COM | 015351109 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 100,000 | $5.351M | 3.0% | $53.51 | — | — | Call | 881624209 |
| — | MIRATI THERAPEUTICS INC | 250,000 | $5.35M | 3.0% | $21.40 | $31.60 | — | COM | 60468T105 |
| — | SAGE THERAPEUTICS INC | 160,000 | $5.13M | 2.9% | $32.06 | $56.65 | — | COM | 78667J108 |
| — | SPECTRANETICS CORP | 350,000 | $5.082M | 2.9% | $14.52 | $13.18 | — | COM | 84760C107 |
| — | OPHTHOTECH CORP | 120,000 | $5.072M | 2.9% | $42.27 | $42.27 | — | COM | 683745103 |
| IHF | ISHARES TR | 39,500 | $4.818M | 2.7% | $121.97 | $121.97 | — | US HLTHCR PR ETF | 464288828 |
| — | NEVRO CORP | 75,000 | $4.22M | 2.4% | $56.27 | $67.51 | — | COM | 64157F103 |
| — | NANOSTRING TECHNOLOGIES INC | 225,000 | $3.425M | 1.9% | $15.22 | $13.25 | — | COM | 63009R109 |
| — | NUVASIVE INC | 70,000 | $3.406M | 1.9% | $48.66 | $46.62 | — | COM | 670704105 |
| IART | INTEGRA LIFESCIENCES HLDGS C | 50,000 | $3.368M | 1.9% | $67.36 * | $31.26 | -0.4% | COM NEW | 457985208 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 40,000 | $3.299M | 1.9% | $82.47 | $81.36 | 0.0% | COM | 09061G101 |
| IHI | ISHARES TR | 25,000 | $3.062M | 1.7% | $122.48 | $122.48 | — | U.S. MED DVC ETF | 464288810 |
| RMD | RESMED INC | 50,000 | $2.891M | 1.6% | $57.82 * | $50.48 | 0.0% | COM | 761152107 |
| — | VALEANT PHARMACEUTICALS INTL | 100,000 | $2.63M | 1.5% | $26.30 | — | — | Call | 91911K102 |
| — | DBV TECHNOLOGIES S A | 45,000 | $2.583M | 1.5% | $57.40 | $66.42 | — | SPONSORED ADR | 23306J101 |
| ACAD | ACADIA PHARMACEUTICALS INC | 75,000 | $2.097M | 1.2% | $27.96 * | $35.23 | -38.0% | COM | 004225108 |
| — | WRIGHT MED GROUP N V | 125,000 | $2.075M | 1.2% | $16.60 | $24.18 | — | ORD SHS 0.03 PAR | N96617118 |
| — | PORTOLA PHARMACEUTICALS INC | 100,000 | $2.04M | 1.2% | $20.40 | $48.90 | — | Call | 737010108 |
| — | ST JUDE MED INC | 36,500 | $2.008M | 1.1% | $55.01 | $55.01 | — | COM | 790849103 |
| VRTX | VERTEX PHARMACEUTICALS INC | 25,253 | $2.007M | 1.1% | $79.48 * | $90.45 | 0.0% | COM | 92532F100 |
| — | ENTELLUS MED INC | 110,000 | $2.001M | 1.1% | $18.19 | $16.86 | — | COM | 29363K105 |
| MDT | MEDTRONIC PLC | 26,578 | $1.993M | 1.1% | $74.99 * | $58.89 | 0.0% | COM | G5960L103 |
| — | ACHILLION PHARMACEUTICALS IN | 250,000 | $1.93M | 1.1% | $7.72 | $8.85 | — | COM | 00448Q201 |
| VCYT | VERACYTE INC | 341,708 | $1.845M | 1.0% | $5.40 * | $8.42 | -29.8% | COM | 92337F107 |
| — | CYNAPSUS THERAPEUTICS INC | 151,535 | $1.803M | 1.0% | $11.90 | $16.29 | — | COM PAR NO PAR | 23257Y859 |
| — | GENMARK DIAGNOSTICS INC | 300,000 | $1.581M | 0.9% | $5.27 | $9.06 | — | COM | 372309104 |
| IHE | ISHARES TR | 9,800 | $1.342M | 0.8% | $136.94 | $136.94 | — | U.S. PHARMA ETF | 464288836 |
| — | TANDEM DIABETES CARE INC | 150,000 | $1.307M | 0.7% | $8.71 | $11.81 | — | COM | 875372104 |
| — | LION BIOTECHNOLOGIES INC | 250,000 | $1.27M | 0.7% | $5.08 | $5.08 | — | COM | 53619R102 |
| — | ALCOBRA LTD | 300,000 | $1.137M | 0.6% | $3.79 | $5.68 | — | SHS | M2239P109 |
| — | PORTOLA PHARMACEUTICALS INC | 40,000 | $816K | 0.5% | $20.40 | $48.90 | — | COM | 737010108 |
| — | CHIASMA INC | 75,000 | $687K | 0.4% | $9.16 | $9.16 | — | COM | 16706W102 |
| — | ENDO INTL PLC | 24,100 | $678K | 0.4% | $28.13 | $28.13 | — | SHS | G30401106 |
| — | VITAE PHARMACEUTICALS INC | 101,188 | $671K | 0.4% | $6.63 | $12.29 | — | COM | 92847N103 |
| — | AKARI THERAPEUTICS PLC | 46,622 | $653K | 0.4% | $14.01 | $18.60 | — | SPONSORED ADR | 00972G108 |
| HRTX | HERON THERAPEUTICS INC | 25,000 | $475K | 0.3% | $19.00 * | $19.73 | 0.0% | COM | 427746102 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 50,000 | $407K | 0.2% | $8.14 | $12.06 | — | SPONDS ADR | 00653A107 |
| — | CLOVIS ONCOLOGY INC | 18,500 | $355K | 0.2% | $19.19 | $19.19 | — | COM | 189464100 |
| — | STRONGBRIDGE BIOPHARMA PLC | 72,726 | $332K | 0.2% | $4.57 | $7.60 | — | COM | G85347105 |
| — | OCERA THERAPEUTICS INC | 45,000 | $132K | 0.1% | $2.93 | $10.04 | — | COM | 67552A108 |